JAK signaling may be behind polymyalgia rheumatica
by Lori SolomonJanus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study publ
Updated on: April 16,2024
18
JAK signaling may be behind polymyalgia rheumatica
by Lori SolomonJanus tyrosine kinase (JAK) signaling may be involved in the pathogenesis of polymyalgia rheumatica (PMR), and tofacitinib may be an effective treatment, according to a pilot study publ
Updated on:April 16,2024
18
